WOK Stock Forecast: WORK Medical Technology Group Ltd. Price Predictions for 2026-2027
Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 16 of 100 as at 12 Sept 2026 — in the weakest quartile.
WOK stock analysis: one number for the whole business
Consensus tells you what everyone already believes. The model scores WORK Medical Technology Group Ltd. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Size (93): Smaller than most of the companies we track.
Momentum (8): The shares have been drifting down relative to others.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
WOK stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on WOK, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
This page is one stock. Monday covers all of them.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. WOK appears on the weeks it earns a place.
WOK vs the S&P 500
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 11 Sept 2026, WORK Medical Technology Group Ltd. returned −100.0% against +17.5% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
WOK analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
WORK Medical Technology Group Ltd. (WOK) financial data
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- −0.0×
- Price / sales
- 0.8×
- Price / book
- 0.0×
- EV / EBITDA
- −1.7×
Cheaper than 75% of US stocks
Cheaper than 74% of US stocks
Cheaper than 92% of US stocks
Cheaper than 70% of US stocks
- Revenue growth (YoY)
- 19.1%
- Earnings growth (YoY)
- —
- Gross margin
- —
- Operating margin
- −65.3%
- Net margin
- −42.0%
Higher than 68% of US stocks
Higher than 16% of US stocks
Higher than 11% of US stocks
- Return on equity
- −19.2%
- Return on assets
- −6.7%
- Dividend yield
- —
Higher than 31% of US stocks
Higher than 29% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
WORK Medical Technology Group Ltd. (WOK) statistics: revenue, profit & scale
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
WORK Medical Technology Group Ltd. has a market value of $8.4M and an enterprise value of $5.8M.
Trailing P/E: −0.0×.
WORK Medical Technology Group Ltd. employs 238 people.
Data provided by Twelve Data
WOK vs competitors
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own WORK Medical Technology Group Ltd. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Frequently asked questions about WOK stock
How does Ticker Nerd's model rank WOK?
As at 12 Sept 2026, WORK Medical Technology Group Ltd. ranks 16 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (93 of 100).
What is the WOK stock forecast for 2030?
No analyst covering WORK Medical Technology Group Ltd. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for WOK are extrapolating price history, which says nothing about the business.
How has WOK stock performed over the past year?
WORK Medical Technology Group Ltd. returned -100.0% over the 12 months to 11 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.
What does WORK Medical Technology Group Ltd. do?
WORK Medical Technology Group Ltd. Class A Ordinary Shares represents equity in WORK Medical Technology Group Ltd., a medical device company focused on the development, manufacturing, and sale of medical consumables and equipment.
About WORK Medical Technology Group Ltd.
WORK Medical Technology Group Ltd. Class A Ordinary Shares represents equity in WORK Medical Technology Group Ltd., a medical device company focused on the development, manufacturing, and sale of medical consumables and equipment. The company’s product lineup includes disposable breathing circuits, endotracheal tubes, laryngeal mask airways, anesthesia kits, oxygen masks, suction sets, laryngoscope blades, KN95 masks, and other respiratory and hospital-use supplies. It serves healthcare providers and distributors in China and in international markets through its operating subsidiaries. WORK Medical Technology Group Ltd. operates within the health technology and medical specialties segment, supplying products used in anesthesia, airway management, infection protection, and general patient care. The shares provide public market exposure to a business centered on medical consumables and devices used across clinical and emergency care settings.
CEO Mr. Shuang Wu · 238 employees · China · https://www.workmedtech.com